Integer Holdings Corp. (ITGR)
86.75
+0.41
(+0.47%)
USD |
NYSE |
Mar 03, 16:00
86.75
0.00 (0.00%)
After-Hours: 20:00
Integer Holdings Research and Development Expense (Annual) : 46.35M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Alphatec Holdings, Inc. | 76.27M |
| QuidelOrtho Corp. | 186.20M |
| Abbott Laboratories | 2.889B |
| Plus Therapeutics, Inc. | 10.58M |
| Molina Healthcare, Inc. | -- |